Clinical Trials

NEW STUDY – Published data on Jupiter Endovascular’s thrombectomy system shows normalization for fully 50% of patients, with all endpoints met

Peer-reviewed Data Published in EuroIntervention Also Demonstrated Vertex System Achieved [...]

By |2026-10-19T16:34:40+00:00October 19, 2026|3rd Party Medical Device Industry News|Comments Off on NEW STUDY – Published data on Jupiter Endovascular’s thrombectomy system shows normalization for fully 50% of patients, with all endpoints met

Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma

Results presented at IMS 2026 show ZENBEXUS in combination with [...]

By |2026-09-25T14:22:13+00:00September 25, 2026|3rd Party Medical Device Industry News|Comments Off on Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
Go to Top